*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| D611 - Drug-induced aplastic anemia - as a primary diagnosis code | D611 - Drug-induced aplastic anemia - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 7.81 | |
| Readmission Rate (%) | 33.93 | |
| Unplanned Readmission Rate (%) | 20.43 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 810: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|
| Total Hospitalizations at DRG | 45,432 | ||
| Total Hospitalizations with ICD D611 - Drug-induced aplastic anemia | 134 | ||
| DRG Share of Total Hospitalizations | 0.14 | ||
| % of Total ICD D611 - Drug-induced aplastic anemia in DRG | 53.17 | ||
| Avg LOS at DRG | 4.42 | ||
| Avg LOS with ICD D611 - Drug-induced aplastic anemia | 5.03 | ||
| Readmission Rate at DRG | 30.74 | ||
| Readmission Rate with ICD D611 - Drug-induced aplastic anemia | 34.68 | ||
| Unplanned Readmission Rate at DRG | 18.94 | ||
| Unplanned Readmission Rate with ICD D611 - Drug-induced aplastic anemia | 23.39 | ||
| Total Medicare payments at DRG | $376,347,273 | ||
| Total Medicare payments with ICD D611 - Drug-induced aplastic anemia | $1,180,138 | ||
| Total Medicare payment per Day at DRG | $1,873 | ||
| Total Medicare payment per Day with ICD D611 - Drug-induced aplastic anemia | $1,751 | ||
| Total Medicare payment per Hospitalization at DRG | $8,284 | ||
| Total Medicare payment per Hospitalization with ICD D611 - Drug-induced aplastic anemia | $8,807 | ||
| Total Medicare Charges at DRG | $1,794,383,177 | ||
| Total Medicare Charges with ICD D611 - Drug-induced aplastic anemia | $7,715,958 | ||
| Avg Charges at DRG | $39,496 | ||
| Avg Charges with ICD D611 - Drug-induced aplastic anemia | $57,582 | ||
| Mortality Rate at DRG | 0.61 | ||
| Mortality Rate with ICD D611 - Drug-induced aplastic anemia | NA | ||
| SNF Discharge Rate at DRG | 7.48 | ||
| SNF Discharge Rate with ICD D611 - Drug-induced aplastic anemia | 8.21 | ||
| Home Discharge Rate at DRG | 67.79 | ||
| Home Discharge Rate with ICD D611 - Drug-induced aplastic anemia | 59.7 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,808,415 | ||||
| Total Hospitalizations with ICD D611 - Drug-induced aplastic anemia | 336 | ||||
| DRG Share of Total Hospitalizations | 5.5 | ||||
| % of Total ICD D611 - Drug-induced aplastic anemia in DRG | 14.05 | ||||
| Avg LOS at DRG | 6.34 | ||||
| Avg LOS with ICD D611 - Drug-induced aplastic anemia | 7.96 | ||||
| Readmission Rate at DRG | 24.2 | ||||
| Readmission Rate with ICD D611 - Drug-induced aplastic anemia | 31.11 | ||||
| Unplanned Readmission Rate at DRG | 16.78 | ||||
| Unplanned Readmission Rate with ICD D611 - Drug-induced aplastic anemia | 20.0 | ||||
| Total Medicare payments at DRG | $21,288,214,047 | ||||
| Total Medicare payments with ICD D611 - Drug-induced aplastic anemia | $4,349,243 | ||||
| Total Medicare payment per Day at DRG | $1,857 | ||||
| Total Medicare payment per Day with ICD D611 - Drug-induced aplastic anemia | $1,626 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
| Total Medicare payment per Hospitalization with ICD D611 - Drug-induced aplastic anemia | $12,944 | ||||
| Total Medicare Charges at DRG | $107,155,481,388 | ||||
| Total Medicare Charges with ICD D611 - Drug-induced aplastic anemia | $27,227,708 | ||||
| Avg Charges at DRG | $59,254 | ||||
| Avg Charges with ICD D611 - Drug-induced aplastic anemia | $81,035 | ||||
| Mortality Rate at DRG | 12.11 | ||||
| Mortality Rate with ICD D611 - Drug-induced aplastic anemia | 15.48 | ||||
| SNF Discharge Rate at DRG | 27.18 | ||||
| SNF Discharge Rate with ICD D611 - Drug-induced aplastic anemia | 14.58 | ||||
| Home Discharge Rate at DRG | 25.81 | ||||
| Home Discharge Rate with ICD D611 - Drug-induced aplastic anemia | 31.55 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 811: RED BLOOD CELL DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 84,943 | ||||
| Total Hospitalizations with ICD D611 - Drug-induced aplastic anemia | 74 | ||||
| DRG Share of Total Hospitalizations | 0.26 | ||||
| % of Total ICD D611 - Drug-induced aplastic anemia in DRG | 3.09 | ||||
| Avg LOS at DRG | 4.83 | ||||
| Avg LOS with ICD D611 - Drug-induced aplastic anemia | 4.76 | ||||
| Readmission Rate at DRG | 29.98 | ||||
| Readmission Rate with ICD D611 - Drug-induced aplastic anemia | 34.85 | ||||
| Unplanned Readmission Rate at DRG | 23.75 | ||||
| Unplanned Readmission Rate with ICD D611 - Drug-induced aplastic anemia | 25.76 | ||||
| Total Medicare payments at DRG | $730,869,349 | ||||
| Total Medicare payments with ICD D611 - Drug-induced aplastic anemia | $685,191 | ||||
| Total Medicare payment per Day at DRG | $1,782 | ||||
| Total Medicare payment per Day with ICD D611 - Drug-induced aplastic anemia | $1,947 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,604 | ||||
| Total Medicare payment per Hospitalization with ICD D611 - Drug-induced aplastic anemia | $9,259 | ||||
| Total Medicare Charges at DRG | $3,626,959,517 | ||||
| Total Medicare Charges with ICD D611 - Drug-induced aplastic anemia | $3,159,317 | ||||
| Avg Charges at DRG | $42,699 | ||||
| Avg Charges with ICD D611 - Drug-induced aplastic anemia | $42,693 | ||||
| Mortality Rate at DRG | 2.39 | ||||
| Mortality Rate with ICD D611 - Drug-induced aplastic anemia | NA | ||||
| SNF Discharge Rate at DRG | 20.54 | ||||
| SNF Discharge Rate with ICD D611 - Drug-induced aplastic anemia | NA | ||||
| Home Discharge Rate at DRG | 49.17 | ||||
| Home Discharge Rate with ICD D611 - Drug-induced aplastic anemia | 55.41 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 834: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,013,774 | ||||
| Total Hospitalizations with ICD D611 - Drug-induced aplastic anemia | 47 | ||||
| DRG Share of Total Hospitalizations | 3.08 | ||||
| % of Total ICD D611 - Drug-induced aplastic anemia in DRG | 1.97 | ||||
| Avg LOS at DRG | 5.34 | ||||
| Avg LOS with ICD D611 - Drug-induced aplastic anemia | 5.89 | ||||
| Readmission Rate at DRG | 28.25 | ||||
| Readmission Rate with ICD D611 - Drug-induced aplastic anemia | 44.19 | ||||
| Unplanned Readmission Rate at DRG | 21.93 | ||||
| Unplanned Readmission Rate with ICD D611 - Drug-induced aplastic anemia | 41.86 | ||||
| Total Medicare payments at DRG | $9,469,067,156 | ||||
| Total Medicare payments with ICD D611 - Drug-induced aplastic anemia | $441,850 | ||||
| Total Medicare payment per Day at DRG | $1,751 | ||||
| Total Medicare payment per Day with ICD D611 - Drug-induced aplastic anemia | $1,595 | ||||
| Total Medicare payment per Hospitalization at DRG | $9,340 | ||||
| Total Medicare payment per Hospitalization with ICD D611 - Drug-induced aplastic anemia | $9,401 | ||||
| Total Medicare Charges at DRG | $43,343,716,813 | ||||
| Total Medicare Charges with ICD D611 - Drug-induced aplastic anemia | $1,980,120 | ||||
| Avg Charges at DRG | $42,755 | ||||
| Avg Charges with ICD D611 - Drug-induced aplastic anemia | $42,130 | ||||
| Mortality Rate at DRG | 3.72 | ||||
| Mortality Rate with ICD D611 - Drug-induced aplastic anemia | NA | ||||
| SNF Discharge Rate at DRG | 20.84 | ||||
| SNF Discharge Rate with ICD D611 - Drug-induced aplastic anemia | 27.66 | ||||
| Home Discharge Rate at DRG | 37.68 | ||||
| Home Discharge Rate with ICD D611 - Drug-induced aplastic anemia | 42.55 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 810: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 393: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 602: CELLULITIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 837: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 6,295 | ||||
| Total Hospitalizations with ICD D611 - Drug-induced aplastic anemia | 33 | ||||
| DRG Share of Total Hospitalizations | 0.02 | ||||
| % of Total ICD D611 - Drug-induced aplastic anemia in DRG | 1.38 | ||||
| Avg LOS at DRG | 3.16 | ||||
| Avg LOS with ICD D611 - Drug-induced aplastic anemia | 3.94 | ||||
| Readmission Rate at DRG | 24.66 | ||||
| Readmission Rate with ICD D611 - Drug-induced aplastic anemia | NA | ||||
| Unplanned Readmission Rate at DRG | 15.4 | ||||
| Unplanned Readmission Rate with ICD D611 - Drug-induced aplastic anemia | NA | ||||
| Total Medicare payments at DRG | $37,992,621 | ||||
| Total Medicare payments with ICD D611 - Drug-induced aplastic anemia | $239,225 | ||||
| Total Medicare payment per Day at DRG | $1,909 | ||||
| Total Medicare payment per Day with ICD D611 - Drug-induced aplastic anemia | $1,840 | ||||
| Total Medicare payment per Hospitalization at DRG | $6,035 | ||||
| Total Medicare payment per Hospitalization with ICD D611 - Drug-induced aplastic anemia | $7,249 | ||||
| Total Medicare Charges at DRG | $201,047,882 | ||||
| Total Medicare Charges with ICD D611 - Drug-induced aplastic anemia | $1,747,059 | ||||
| Avg Charges at DRG | $31,938 | ||||
| Avg Charges with ICD D611 - Drug-induced aplastic anemia | $52,941 | ||||
| Mortality Rate at DRG | 0.25 | ||||
| Mortality Rate with ICD D611 - Drug-induced aplastic anemia | NA | ||||
| SNF Discharge Rate at DRG | 5.77 | ||||
| SNF Discharge Rate with ICD D611 - Drug-induced aplastic anemia | NA | ||||
| Home Discharge Rate at DRG | 76.76 | ||||
| Home Discharge Rate with ICD D611 - Drug-induced aplastic anemia | 75.76 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 67 |
| HOAG MEMORIAL HOSPITAL PRESBYTERIAN | ONE HOAG DRIVE | NEWPORT BEACH | CA | 92663 | 11 |
| No | ICD Diagnosis Code | Description |
|---|---|---|
| 1 | T451X5A | Adverse effect of antineoplastic and immunosuppressive drugs, initial encounter |